All news

UBS cuts Carlyle to neutral on growth doubts

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

UBS downgraded Carlyle Group (NASDAQ:CG) from Buy to Neutral and cut its price target, citing diminished confidence in the firm's growth profile and its ability to hit 2028 financial objectives. UBS's fee-related earnings forecast implies a much lower compound annual growth rate than Carlyle targets, trimming 2027 and 2028 distributable earnings estimates.

Read original source

UBS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.